Estradiol is a naturally occurring estrogen hormone and one of the primary female sex hormones. It plays a crucial role in regulating the menstrual cycle, reproductive system, and secondary sexual characteristics. Estradiolis widely used in hormone replacement therapy (HRT) for menopausal symptoms, contraception, and in the management of certain hormone-sensitive conditions such as osteoporosis or hypogonadism. Pharmacologically, estradiol works by binding to estrogen receptors (ERα and ERβ) in target tissues, modulating gene transcription and influencing cell growth, differentiation, and metabolism. Both natural and synthetic formulations are available, administered via oral, transdermal, injectable, or topical routesdepending on therapeutic needs.

BRAND NAMES

  • estrace: cream

  • climara: film, extended release

  • minivelle: film, extended release

  • divigel: gel

  • elestrin: gel, metered

  • estrogel: gel, metered

  • imvexxy: insert

  • estring: insert, extended release

  • evamist: spray

  • menostar: system

  • vivelle-dot: system

  • vagifem: tablet

MECHANISM OF ACTION

Estradiol is a potent estrogen that exerts its effects by binding to intracellular estrogen receptors (ERα and ERβ) in target tissues. Once bound, the hormone-receptor complex translocates to the nucleus and interacts with estrogen response elements (EREs) on DNA, modulating the transcription of estrogen-responsive genes.

PHARMACOKINETICS

Absorption

Estradiol is well absorbed following oral, transdermal, injectable, or vaginal administration

Distribution

Estradiol has a moderate volume of distribution, typically around 2–4 L/kg in adults, reflecting its extensive distribution into estrogen-sensitive tissues such as the uterus, breasts, liver, and adipose tissue.

Metabolism

Estradiol is extensively metabolized in the liver through phase I and phase II reactions. In phase I, estradiol is primarily oxidized to estrone and to a lesser extent to estriol, which are less potent estrogens.

Elimination

Estradiol and its metabolites are primarily eliminated via the urine and bile. After hepatic metabolism, conjugated metabolites (glucuronides and sulfates) are excreted in the urine, while some are secreted into the bile and eliminated in the feces.

PHARMACODYNAMICS

Estradiol, the most potent natural estrogen, exerts its effects by diffusing through cell membranes and binding to intracellular estrogen receptors (ERα and ERβ). The estradiol–receptor complex then translocates to the nucleus, where it binds to estrogen response elements on DNA and regulates gene transcription, leading to changes in protein synthesis.

ADMINISTRATION

Estradiol can be administered through multiple routes depending on the clinical indication and patient needs. It is commonly given orally, where it undergoes first-pass metabolism in the liver, or transdermally as patches, gels, or sprays, which provide more stable blood levels and avoid hepatic metabolism.

DOSAGE AND STRENGTH

The dosage and strength of estradiol vary depending on the indication, route of administration, and patient characteristics. For hormone replacement therapy, oral estradiol is typically prescribed in doses ranging from 0.5 to 2 mg daily, while transdermal patches commonly deliver 25 to 100 micrograms per day.

DRUG INTERACTIONS

Estradiol is subject to several clinically important drug interactions, mainly due to its metabolism in the liver by cytochrome P450 enzymes. Enzyme inducers such as rifampicin, phenytoin, carbamazepine, and phenobarbital can increase the metabolism of estradiol, thereby reducing its efficacy.

FOOD INTERACTIONS

Food can influence the absorption and metabolism of estradiol, particularly with oral administration. Taking estradiol with food may slightly improve its absorption and reduce gastrointestinal discomfort, although it does not significantly alter overall bioavailability.

CONTRAINDICATIONS

Estradiol is contraindicated in individuals with known or suspected estrogen-dependent malignancies such as breast or endometrial cancer, undiagnosed abnormal genital bleeding, and active or past history of thromboembolic disorders including deep vein thrombosis or pulmonary embolism.

SIDE EFFECTS

  1. Nausea and vomiting 

  2. Breast tenderness or enlargement 

  3. Headache or migraine 

  4. Weight gain and fluid retention 

  5. Mood changes 

  6. Irregular vaginal bleeding or spotting 

  7. Abdominal cramps or bloating 

  8. Increased risk of thromboembolic events.

TOXICITY

Toxicity from estradiol is usually associated with excessive dosing or prolonged use and primarily reflects an exaggeration of its pharmacological effects. Common manifestations include severe nausea, vomiting, breast tenderness, fluid retention, and abnormal uterine bleeding. High levels of estradiol can increase the risk of serious complication.

Image
slide_1
CAS Number
Estradiol valerate STD-979-32-8: IMP-A-50-28-2: IMP-C-95959-20-9: IMP-D-1359847-37-2: IMP-E-63042-28-4
CAS Number
50-28-2
Alternate CAS Number
35380-71-3(Hemihydrate Salt)
CAS Number
Estradiol STD-50-28-2; 35380-71-3(Hemihydrate Salt): IMP-A-53-16-7: IMP-B-57-91-0: IMP-C-6171-48-8
CAS Number
Estradiol benzoate STD-50-50-0: IMP-A-50-28-2: IMP-B-NA: IMP-C-4147-13-1: IMP-E-6045-53-0: IMP-G-2393-53-5